24 Jan 2017 GeoVax Announces Initiation of HIV Human Clinical Trial
18 Jan 2017 GeoVax to collaborate with Georgia State on development of hepatitis B therapeutic vaccine
18 Jan 2017 Agenus announces collaboration with the National Cancer Institute to evaluate the combination of Pembrolizumab (Keytruda®, Merck & Co., Inc.) with Prophage™ (Agenus Inc.) autologous vaccine
13 Jan 2017 Sanaria's PfSPZ Vaccine Provides High Level Defense Against Malaria In U.S. Navy and Army Clinical Investigation
13 Jan 2017 Protein Sciences Zika Vaccine Shows Good Results in Preclinical Testing
09 Jan 2017 Aduro Biotech Announces Clinical Collaboration with Merck to Evaluate the Combination of Aduro’s CRS-207 with Merck’s KEYTRUDA® (pembrolizumab) for the Treatment of Gastric Cancer
04 Jan 2017 Bavarian Nordic Provides Update on Anticipated Timing of PROSPECT Study
04 Jan 2017 Bavarian Nordic Initiates Trial of CV301 in Combination with Nivolumab in Patients with Lung Cancer
23 Dec 2016 Gradalis Announces a Novel Combination Study of Vigil® EATC
22 Dec 2016 Inovio’s Zika Vaccine Generates Robust Immune Responses in First Human Study
21 Dec 2016 Astellas Announces FDA Fast Track Designation for ASP0892, DNA Vaccine for Mitigation of Severe Hypersensitivity Reactions Due to Peanut Allergy
19 Dec 2016 Pfizer Receives Approval in the European Union for Nimenrix™ (Meningococcal Group A, C, W-135, and Y Conjugate Vaccine) in Infants Six Weeks of Age and Older
13 Dec 2016 Zika virus: top EU-groups join forces in quest for vaccine
11 Dec 2016 AXON’s Alzheimer Tau Vaccine Phase 1 Study Results Published in Lancet Neurology
09 Dec 2016 NW Bio Provides Update About Phase 3 Trial Of DCVax®-L for Newly Diagnosed Glioblastoma Multiforme Brain Cancer
09 Dec 2016 Valneva Receives FDA and European Approvals to Start Clinical Testing of Lyme Disease Vaccine Candidate
08 Dec 2016 Selecta Presents Phase 1 Clinical Data for Lead Product Candidate, SEL-212, in Patients with Hyperuricemia at 11th Annual IMVAC Summit
08 Dec 2016 Transgene: UC Davis to Conduct Phase 2 Trial of the Combination of TG4010 with Opdivo® (nivolumab) for 2nd Line Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC)
07 Dec 2016 ISA Pharmaceuticals Advances Personalized Cancer Treatment
06 Dec 2016 Boston Biomedical Announces First Clinical Data for Investigational WT1 Cancer Peptide Vaccine, DSP-7888, at ASH Annual Meeting & Exposition
06 Dec 2016 Heat Biologics Presents Topline HS-110/Nivolumab Combination Lung Cancer Results
01 Dec 2016 VAXIMM Presents Preclinical Data on Three Novel Oral T-Cell Cancer Immunotherapies at EORTC-NCI-AACR Symposium
29 Nov 2016 BiondVax Phase 2b Trial Preliminary Safety Results: The Universal Flu Vaccine Candidate is Safe and Well Tolerated
28 Nov 2016 OncoPep Announces Initiation of Phase 1b Clinical Trial of PVX-410 in Smoldering Multiple Myeloma and Upcoming Presentation of Positive Results from Phase 1/2a Clinical Trial at ASH
28 Nov 2016 OncoPep Announces Initiation of Phase 1b Clinical Trial of PVX-410 in Triple Negative Breast Cancer

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing